Navigation Links
Longer Lung Cancer Survival

According to the American Cancer Society, there are 172,000 Americans diagnosed with lung cancer each year. Because there are no early screening tests, many of these cancers are caught in their later stages, making them difficult to treat. A new drug is now helping patients who have failed standard treatment.
By going after that protein, the drug stops the cancer from growing. Studies show as many as 20 percent of patients //taking the drug actually had their tumors shrink by 50 percent or more. Another 35 percent had symptoms relieved.
Marcie has stage four lung cancer.Her first dose of chemotherapy didn’t work. More chemo and radiation followed, but her cancer didn’t go away. She says, "You want to hear words of encouragement and hope. You know, you just long for something."

Those words of hope came when she met Oncologist Karen Kelly, M.D., who introduced her to a promising drug called ZD-1839. ZD-1839, specifically targets a specific protein on a cancer cell,Says Dr. Kelly, of University of Colorado Health Sciences Center in Denver.

Dr. Kelly says, "It really provides them with a chance to have prolonged survival with a high quality of life. It’s not a magic bullet, but it really has helped a lot of patients with lung cancer."

Marcie takes the drug every day. She says, "This drug has given me renewed life and renewed hope and renewed faith. I live now with a love of life and enjoy every day and try not to take any day for granted." With more energy and more strength, she’s able to live life to the fullest.

On May 5, 2003, the FDA approved this drug for advanced stage lung cancer under the name Iressa. The major side effect of the drug is a mild skin rash, which can be treated with medication if needed. It is currently only offered to patients who have failed at least two different treatments of chemotherapy. The drug is given once a day in tablet form.

If you would like more information, plea se contact:

Tina Russell, R.N., OCM
Oncology Certified Nurse
University of Colorado Health Sciences Center
4200 East 9th Ave., B171
Denver, CO 80262
(720) 848-024

Related medicine news :

1. Longer airway in males increases sleep disorder risk
2. Patients Are Given Catheter Longer Than Necessary
3. Fat Patients Require Longer Needles
4. Patients In Ontario Wait Longer For Treatment
5. Quality Platelets and Improved Blood Availability No Longer a Pipe Dream
6. Oscar Winners Live Longer Than Co-Competitors
7. Threat from Chikungunya, No Longer a Fear
8. Cyber Sex, No Longer A Fantasy Of The Mind
9. Kids Face a Slim Chance of Growing Obese, If Breastfed Longer Than Three Months
10. Misleading Health Claims On Food Labels No Longer Allowed in EU
11. Slow Learners Have Longer Memories
Post Your Comments:

(Date:11/27/2015)... ... 27, 2015 , ... An inventor, from Hopkinsville, Ky., thought ... at home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. ... doing so, it could help to prevent potential overdose situations. As a result, ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind challenges ... health and wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular ... experienced by parents and bring advice from parenting experts within their reach. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and ... of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. ... 5.10 up-to-date with a version of Asterisk that will receive not only security ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... workshops to discuss bioavailability and the need to integrate dose form selection in ... collaboration with OBN, the membership organization supporting and bringing together the UK’s emerging ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Japanese therapeutic drug monitoring market, including emerging tests, ...
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda SyMRI ... (MR-bilder) för patienter med multipel skleros ... forskningsavtal med SyntheticMR AB för att kunna ... på sjukhuset. Med SyMRI kan man generera ...
Breaking Medicine Technology: